Loading insider details...
Beta
Latest Form 4 (Sep 4, 2026): Sale of 453 EDIT shares, $1.4K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 4, 2026 | Editas Medicine, Inc. (EDIT) | Sale | 453 | $1.4K |
| Aug 5, 2026 | Editas Medicine, Inc. (EDIT) | Sale | 678 | $1.7K |
| Jun 5, 2026 | Editas Medicine, Inc. (EDIT) | Sale | 464 | $1.3K |
| Mar 16, 2026 | Editas Medicine, Inc. (EDIT) | Grant/Award | 292,856 | n/a |
| Mar 4, 2026 | Editas Medicine, Inc. (EDIT) | Sale | 474 | $957.48 |
| Dec 4, 2025 | Editas Medicine, Inc. (EDIT) | Sale | 461 | $992.58 |
| Sep 4, 2025 | Editas Medicine, Inc. (EDIT) | Sale | 458 | $1.2K |
| Aug 8, 2025 | Editas Medicine, Inc. (EDIT) | Sale | 679 | $1.8K |
| Jun 4, 2025 | Editas Medicine, Inc. (EDIT) | Sale | 446 | $768.90 |
| Apr 8, 2025 | Editas Medicine, Inc. (EDIT) | Grant/Award | 34,672 | n/a |